NYR
NYRADA CDI FORUS [NYR]
Healthcare · ASX Small Cap
$0.6400 -3.8%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +3First seen: 2026-02-25
Score Breakdown
Technical63
Catalyst53
Sentiment50
Fundamental37
Momentum74
Risk Gate35
Active Signals
Bullish Signals
- RSI approaching oversold
- Above 200-day MA (long-term uptrend)
- Low cash runway (4 quarters) - dilution risk
- Very high P/S ratio (68.5x)
- CANSLIM S: Tight float (45%)
- Strong 12-1 momentum (+776%)
- Excellent risk-adjusted momentum (Sharpe 2.4)
- Altman Z-Score in distress zone (1.72 < 1.81)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Piotroski F-Score weak (3/9)
- Deeply negative margins (-234%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Director Options Issue
NONE Change of Director's Interest Notice - RW
NONE Change of Director's Interest Notice - MF
Announcement tone +3pts
Recent ASX Announcements
| 2026-02-20 | Director Options Issue |
| 2026-02-20 | Change of Director's Interest Notice - RW |
| 2026-02-20 | Change of Director's Interest Notice - MF |
| 2026-02-20 | Change of Director's Interest Notice - JM |
| 2026-02-20 | Change of Director's Interest Notice - ID |
Key Metrics
$162.9M
Market Cap
706K
Avg Volume
1.3x
Vol Ratio
$0.09 — $1.44
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-71.0%
ROE
-234.3%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 44% |
| L | Leader vs Laggard | laggard | RS: -2 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #35 of 119 · Sector avg: 51
View all Healthcare signals →